Philip Morris to invest $232 million to expand ZYN production at Kentucky plant

Philip Morris International (PM.N) announced on Tuesday that it will invest $232 million to increase the production capacity of ZYN nicotine pouches at its Owensboro, Kentucky plant to meet rising demand. The investment will be made through one of PMI's Swedish Match affiliates, following a recent $600 million investment to establish a ZYN manufacturing facility in Colorado.

Why it Matters
Shipments of ZYN grew by 54% in the second quarter, as reported in July, but high demand led to short-term supply chain challenges, affecting volume growth. ZYN, a nicotine pouch alternative to traditional chewing tobacco, does not contain tobacco, according to Philip Morris.

Context
Philip Morris acquired Swedish Match, ZYN's parent company, in a $16 billion deal in 2022 as part of its strategy to diversify from traditional tobacco products in response to stricter regulations and growing health awareness. In June, PMI halted online sales of ZYN across the U.S. after receiving a subpoena from Washington, D.C., related to compliance with the city's 2022 ban on flavored tobacco sales. Concerns about illicit sales due to supply gaps were also raised during the company's second-quarter conference call in July.

What’s Next
The expansion at the Kentucky facility is already underway and is expected to be completed by the second quarter of 2025. To meet production needs, the plant will shift to 24/7 operations starting in the fourth quarter of this year. PMI aims for the expansion to provide around 900 million cans of ZYN by 2025.

Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.